Fumaric acid esters therapy: A new treatment modality in pityriasis rubra pilaris? [15]

British Journal of Dermatology

Volumn 152, Issue 2, 2005, Pages 388-389

  Coras, B ^a   Vogt, T H ^a   Ulrich, H ^a   Landthaler, M ^a   Hohenleutner, U ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CALCIUM SALT; ETRETIN; FUMADERM; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ETHYL ESTER; ISOTRETINOIN; MAGNESIUM SALT; RETINOID; SALICYLIC ACID; TAZAROTENE; UREA; ZINC DERIVATIVE;

ACNE; ADOLESCENT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIARRHEA; FATIGUE; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; LABORATORY TEST; LETTER; MALE; NAUSEA; PHOTOTHERAPY; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ULTRAVIOLET B RADIATION;

ADOLESCENT; DERMATOLOGIC AGENTS; FUMARATES; HUMANS; MALE; PITYRIASIS RUBRA PILARIS;

EID: 14844295399     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06356.x     Document Type: Letter

References (5)

1. Artik S, Megahed M, Ruzicka T. Pityriasis rubra pilaris. Hautarzt 2003; 54:858-63.
2. Hoefnagel JJ, Thio HB, Willemenze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149:363-9.
3. de Jong P, Bezemer AC, Zomerdijk TP et al. Selective stimulation of helper 2 cytokine responses by the antipsoriasis agent monomethylfumarate. Eur J Immunol 1996; 26:2067-74.
4. Altmeyer PY, Matthes U, Pawlak F et al. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol 1994; 30:977-81.
5. Mrowietz U, Christophers E, Altmeyer PY. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 1999; 141:424-9.